This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Remuzzi G et al. (2006) Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116: 288–296
Asselbergs FW et al. (2004) Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 110: 2809–2816
Gaspari F et al. (1995) Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 6: 257–263
Ruggenenti P and Remuzzi G (2006) Time to abandon microalbuminuria? Kidney Int 70: 1214–1222
Dirks JH et al. (2006) Meeting report on the Bellagio Conference 'prevention of vascular diseases in the emerging world: an approach to global health equity'. Kidney Int 70: 1397–1402
Acknowledgements
The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Ruggenenti, P., Remuzzi, G. How should patients with, or at risk of, cardiovascular disease be screened for chronic kidney disease?. Nat Rev Nephrol 3, 126–127 (2007). https://doi.org/10.1038/ncpneph0406
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0406